Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.16 - $0.34 $5,488 - $11,662
34,300 Added 2.63%
1,339,841 $267,000
Q4 2022

Feb 10, 2023

BUY
$0.22 - $15.3 $188 - $13,142
859 Added 0.07%
1,305,541 $300,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $21.78 $0 - $3.03 Million
139,081 Added 11.93%
1,304,682 $294,000
Q2 2022

Aug 12, 2022

SELL
$0.0 - $0.0 $0 - $0
-7,102 Reduced 0.61%
1,165,601 $513,000
Q1 2022

May 13, 2022

SELL
$0.0 - $0.0 $0 - $0
-315,653 Reduced 21.21%
1,172,703 $1.22 Million
Q4 2021

Feb 14, 2022

SELL
$0.0 - $6.95 $0 - $56,760
-8,167 Reduced 0.55%
1,488,356 $1.61 Million
Q2 2021

Aug 13, 2021

BUY
$7.46 - $9.49 $11.2 Million - $14.2 Million
1,496,523 New
1,496,523 $4.34 Million

Others Institutions Holding YCBD

About cbdMD, Inc.


  • Ticker YCBD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,555,600
  • Market Cap $27.3M
  • Description
  • cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...
More about YCBD
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.